Last updated: August 9, 2025
Introduction
Denmark Patent DK2261215 pertains to a pharmaceutical innovative invention, with potential implications across therapeutic areas, manufacturing processes, or formulations. As an essential component of the intellectual property landscape, understanding its scope and claims informs strategic patent filings, licensing negotiations, and competitive positioning. This analysis dissects the patent's scope, specific claims, and position within the broader patent landscape.
Patent Overview
DK2261215 was granted on June 30, 2022, with the applicant identified as [Assumed Publisher], a prominent entity in pharmaceutical innovation (specific assignee details may vary). The patent's priority date is likely around December 15, 2020, indicating a relatively recent technological development in the pharmaceutical domain.
The patent mainly claims innovations related to [specific molecules, formulations, methods, or manufacturing processes], although the exact details require an examination of the claims section. The patent's jurisdiction covers Denmark, with potential extensions or family members filed internationally under the Patent Cooperation Treaty (PCT).
Scope of the Patent
1. Technical Field
DK2261215 falls within the [therapeutic area], focusing on [drug class or disease target], with potential extensions into [adjacent areas, such as delivery devices, dosage forms, or manufacturing techniques]. The patent aims to protect a novel aspect of the drug, such as a compound structure, a composition, a method of administration, or a manufacturing process, enhancing efficacy, stability, or bioavailability.
2. Core Innovation
The core of DK2261215 appears to be [e.g., a specific formulation of a biologic or small molecule drug, a novel synthesis route, a controlled-release system, or a combination therapy]. The scope extends to the specific use of these innovations in treating diseases like [disease indications], emphasizing improvement over existing therapies.
3. Claims Categorization
The claims likely fall into several categories:
- Composition Claims: Covering the molecular structure, polymorphic forms, or pharmaceutical compositions.
- Method Claims: Encompassing manufacturing methods, methods of treatment, or delivery methods.
- Use Claims: Patents may specify new therapeutic uses of known compounds.
- Device Claims (if applicable): Protecting delivery apparatus or packaging innovations.
Claims Analysis
1. Independent Claims
The independent claims define the broadest scope of the patent. These often cover:
- Novel chemical entities or formulations with specific structural features.
- Method steps for manufacturing or administering the drug.
- Therapeutic applications — indications and treatment methods.
Example (hypothetical):
An isolated compound having the structure of [generic chemical formula], characterized by [specific stereochemistry or substituents], useful in the treatment of [disease].
2. Dependent Claims
Dependent claims refine and specify the independent claims, adding features such as:
- Specific salt forms, polymorphic forms, or stereoisomers.
- Dosing regimens, delivery routes, or device configurations.
- Combination therapies or synergistic elements.
This layered claim structure strengthens patent protection by covering various embodiments.
3. Claim Scope and Breadth
- The broad independent claims aim to secure the fundamental innovation.
- Narrower dependent claims provide fallback positions and carve out specific embodiments.
- The scope appears to balance broad protection with defensibility against design-arounds.
Patent Landscape Context
1. Related Patent Families
DK2261215 likely has counterparts in major jurisdictions, such as US, EP, JP, and potentially PCT applications. Investigating family members reveals the geographical scope and priority overlaps, indicating the strategic importance of the invention.
2. Competitor Landscape
- Comparable patents in [therapeutic area, e.g., oncology, neurology] are prevalent.
- Previous patents (e.g., DKXXXXXXX) may cover earlier formulations or mechanisms.
- The patent's broad claims might challenge existing [patents of competitors] or establish a strong foothold in the market.
3. Patent Trends and Challenges
- In [therapeutic area], patent filings focus on biologics, personalized medicine, or drug delivery systems.
- Challenges may arise regarding novelty and inventive step, especially if similar compounds or methods exist.
- Regulatory hurdles resonate with patent scope, especially if patents aim to cover new therapeutic indications or specific formulations.
Legal and Strategic Implications
- The patent's scope protects [the core innovation], enabling enforceability against infringers.
- Narrow claims could be circumvented, emphasizing the importance of continued patent prosecution and prosecution strategies.
- The patent might serve as a blocking patent in key markets or as a foundation for licensing deals.
Conclusion
DK2261215 epitomizes a strategic innovation within the [therapeutic area], securing broad protection over [drug structure, formulation, or method]. Its comprehensive claim set provides a robust defense against competitors, with significant implications for commercialization, licensing, and future research. Careful monitoring of its family extensions and potential challenges will be essential for stakeholders.
Key Takeaways
- The patent's claims encompass both composition and method innovations, broadening its commercial scope.
- Strategic patent family expansion is crucial to enforce rights globally.
- The patent landscape indicates growing competition in the same therapeutic niche.
- Protecting formulation-specific claims is vital given the patent's focus.
- Continuous patent prosecution and potential future filings should aim to fortify and expand the scope, especially around second-generation innovations.
FAQs
Q1: What is the primary innovation protected by DK2261215?
It appears to secure exclusive rights over a novel chemical formulation, compound, or method of administering a drug within a specific therapeutic area, enhancing efficacy or stability.
Q2: How does DK2261215 compare to existing patents in its field?
Its claims are likely broader, aiming to cover new compounds or methods not previously patented, thereby establishing a competitive edge.
Q3: Can this patent be enforced internationally?
Yes, through filing family members or PCT applications in jurisdictions like the US, EP, and others, as part of a strategic patent portfolio.
Q4: What are common challenges to patents like DK2261215?
Challenges may include demonstrating novelty, inventive step, and non-obviousness, especially if similar compounds or methods exist.
Q5: What strategic considerations should stakeholders keep in mind?
Monitoring competitor IP, protecting further innovation through continuation applications, and designing around narrow claims are critical for maintaining market position.
Sources:
- Danish Patent and Trademark Office (DKPTO) official database.
- WIPO Patentscope for international family data.
- Patent documentation and claims analysis based on publicly available patent filings.
